Skin Analytics valuation, funding and investors
Skin Analytics works in AI dermatology platform development, based in London, United Kingdom. Founded in 2012, it has about 125 employees.
VALUATION · TODAY
$113M +0% after Series B
Range $68.2M – $130M · Grade BTODAY
+12 MO
$50.0M
$100M
$150M
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Series A $5.19M
Series B $19.9M
ValuationBefore first round12-month outlook: where it points, how wide it fansHover the past: the outlook shows what was predicted then
HEADCOUNT · TODAY125 employees
+6%6m growth
+33%1y growth
+76%2y growth
50
100
150
Data from Jan 2021
Predicted in 1 yr $113M +0% vs today
Predicted next raise $13.6M if a round comes
Winding-down probability 0%
- Last round
- Series B · $19.9M · Apr 2025
- Valuation at last round
- $70.0M
- Headcount
- 125 · growing
- Grade
- B
- Founded
- 2012
Skin Analytics valuation today
VCMC values Skin Analytics at $113M today, with a range of $68.2M to $130M and a grade of B. The valuation starts from its last funding round, a Series B round in Apr 2025.
Valuation by date (181 rows)
Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.
| Date | Valuation | Range | Predicted in 1 yr | Phase | Headcount | Trend | Grade | Winding-down probability |
|---|---|---|---|---|---|---|---|---|
| 1 Jan 2012 | $2.92M | $1.06M – $8.03M | $2.99M (+2%) | before first round | – | unknown | D | 0% |
| 1 Feb 2012 | $2.92M | $1.06M – $8.03M | $3.01M (+3%) | before first round | – | unknown | D | 0% |
| 1 Mar 2012 | $2.92M | $1.06M – $8.03M | $3.02M (+3%) | before first round | – | unknown | D | 0% |
| 1 Apr 2012 | $2.92M | $1.06M – $8.03M | $3.03M (+4%) | before first round | – | unknown | D | 0% |
| 1 May 2012 | $2.92M | $1.06M – $8.03M | $3.04M (+4%) | before first round | – | unknown | D | 0% |
| 1 Jun 2012 | $2.92M | $1.06M – $8.03M | $3.05M (+4%) | before first round | – | unknown | D | 0% |
| 1 Jul 2012 | $2.92M | $1.06M – $8.03M | $3.06M (+5%) | before first round | – | unknown | D | 0% |
| 1 Aug 2012 | $2.94M | $1.07M – $8.07M | $3.08M (+5%) | before first round | – | unknown | D | 0% |
| 1 Sep 2012 | $2.95M | $1.07M – $8.10M | $3.09M (+5%) | before first round | – | unknown | D | 0% |
| 1 Oct 2012 | $2.96M | $1.08M – $8.13M | $3.10M (+5%) | before first round | – | unknown | D | 0% |
| 1 Nov 2012 | $2.97M | $1.08M – $8.16M | $3.11M (+5%) | before first round | – | unknown | D | 0% |
| 1 Dec 2012 | $2.98M | $1.09M – $8.19M | $3.13M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jan 2013 | $2.99M | $1.09M – $8.22M | $3.14M (+5%) | before first round | – | unknown | D | 0% |
| 1 Feb 2013 | $3.01M | $1.09M – $8.26M | $3.15M (+5%) | before first round | – | unknown | D | 0% |
| 1 Mar 2013 | $3.02M | $1.10M – $8.29M | $3.16M (+5%) | before first round | – | unknown | D | 0% |
| 1 Apr 2013 | $3.03M | $1.10M – $8.32M | $3.17M (+5%) | before first round | – | unknown | D | 0% |
| 1 May 2013 | $3.04M | $1.11M – $8.35M | $3.19M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jun 2013 | $3.05M | $1.11M – $8.39M | $3.20M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jul 2013 | $3.06M | $1.12M – $8.42M | $3.21M (+5%) | before first round | – | unknown | D | 0% |
| 1 Aug 2013 | $3.08M | $1.12M – $8.45M | $3.22M (+5%) | before first round | – | unknown | D | 0% |
| 1 Sep 2013 | $3.09M | $1.12M – $8.49M | $3.24M (+5%) | before first round | – | unknown | D | 0% |
| 1 Oct 2013 | $3.10M | $1.13M – $8.52M | $3.25M (+5%) | before first round | – | unknown | D | 0% |
| 1 Nov 2013 | $3.11M | $1.13M – $8.55M | $3.26M (+5%) | before first round | – | unknown | D | 0% |
| 1 Dec 2013 | $3.13M | $1.14M – $8.58M | $3.28M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jan 2014 | $3.14M | $1.14M – $8.62M | $3.29M (+5%) | before first round | – | unknown | D | 0% |
| 1 Feb 2014 | $3.15M | $1.15M – $8.65M | $3.30M (+5%) | before first round | – | unknown | D | 0% |
| 1 Mar 2014 | $3.16M | $1.15M – $8.68M | $3.31M (+5%) | before first round | – | unknown | D | 0% |
| 1 Apr 2014 | $3.17M | $1.16M – $8.72M | $3.33M (+5%) | before first round | – | unknown | D | 0% |
| 1 May 2014 | $3.19M | $1.16M – $8.75M | $3.34M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jun 2014 | $3.20M | $1.16M – $8.79M | $3.35M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jul 2014 | $3.21M | $1.17M – $8.82M | $3.37M (+5%) | before first round | – | unknown | D | 0% |
| 1 Aug 2014 | $3.22M | $1.17M – $8.86M | $3.38M (+5%) | before first round | – | unknown | D | 0% |
| 1 Sep 2014 | $3.24M | $1.18M – $8.89M | $3.39M (+5%) | before first round | – | unknown | D | 0% |
| 1 Oct 2014 | $3.25M | $1.18M – $8.93M | $3.41M (+5%) | before first round | – | unknown | D | 0% |
| 1 Nov 2014 | $3.26M | $1.19M – $8.96M | $3.42M (+5%) | before first round | – | unknown | D | 0% |
| 1 Dec 2014 | $3.28M | $1.19M – $9.00M | $3.43M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jan 2015 | $3.29M | $1.20M – $9.03M | $3.45M (+5%) | before first round | – | unknown | D | 0% |
| 1 Feb 2015 | $3.30M | $1.20M – $9.07M | $3.46M (+5%) | before first round | – | unknown | D | 0% |
| 1 Mar 2015 | $3.31M | $1.21M – $9.10M | $3.47M (+5%) | before first round | – | unknown | D | 0% |
| 1 Apr 2015 | $3.33M | $1.21M – $9.14M | $3.49M (+5%) | before first round | – | unknown | D | 0% |
| 1 May 2015 | $3.34M | $1.22M – $9.17M | $3.50M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jun 2015 | $3.35M | $1.22M – $9.21M | $3.51M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jul 2015 | $3.37M | $1.23M – $9.24M | $3.53M (+5%) | before first round | – | unknown | D | 0% |
| 1 Aug 2015 | $3.38M | $1.23M – $9.28M | $3.62M (+7%) | before first round | – | unknown | D | 0% |
| 1 Sep 2015 | $3.39M | $1.23M – $9.32M | $3.72M (+10%) | before first round | – | unknown | D | 0% |
| 1 Oct 2015 | $3.41M | $1.24M – $9.35M | $3.81M (+12%) | before first round | – | unknown | D | 0% |
| 1 Nov 2015 | $3.42M | $1.24M – $9.39M | $3.92M (+15%) | before first round | – | unknown | D | 0% |
| 1 Dec 2015 | $3.43M | $1.25M – $9.43M | $4.02M (+17%) | before first round | – | unknown | D | 0% |
| 1 Jan 2016 | $3.45M | $1.25M – $9.47M | $4.13M (+20%) | before first round | – | unknown | D | 0% |
| 1 Feb 2016 | $3.46M | $1.26M – $9.50M | $4.24M (+23%) | before first round | – | unknown | D | 0% |
| 1 Mar 2016 | $3.47M | $1.26M – $9.54M | $4.35M (+25%) | before first round | – | unknown | D | 0% |
| 1 Apr 2016 | $3.49M | $1.27M – $9.58M | $4.47M (+28%) | before first round | – | unknown | D | 0% |
| 1 May 2016 | $3.50M | $1.27M – $9.61M | $4.59M (+31%) | before first round | – | unknown | D | 0% |
| 1 Jun 2016 | $3.51M | $1.28M – $9.65M | $4.71M (+34%) | before first round | – | unknown | D | 0% |
| 1 Jul 2016 | $3.53M | $1.28M – $9.69M | $4.83M (+37%) | before first round | – | unknown | D | 0% |
| 1 Aug 2016 | $3.62M | $1.32M – $9.95M | $4.96M (+37%) | before first round | – | unknown | D | 0% |
| 1 Sep 2016 | $3.72M | $1.35M – $10.2M | $5.10M (+37%) | before first round | – | unknown | D | 0% |
| 1 Oct 2016 | $3.82M | $1.39M – $10.5M | $5.23M (+37%) | before first round | – | unknown | D | 0% |
| 1 Nov 2016 | $3.92M | $1.43M – $10.8M | $5.38M (+37%) | before first round | – | unknown | D | 0% |
| 1 Dec 2016 | $4.02M | $1.46M – $11.1M | $5.52M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jan 2017 | $4.13M | $1.50M – $11.3M | $5.66M (+37%) | before first round | – | unknown | D | 0% |
| 1 Feb 2017 | $4.24M | $1.54M – $11.7M | $5.82M (+37%) | before first round | – | unknown | D | 0% |
| 1 Mar 2017 | $4.35M | $1.58M – $11.9M | $5.96M (+37%) | before first round | – | unknown | D | 0% |
| 1 Apr 2017 | $4.46M | $1.63M – $12.3M | $6.12M (+37%) | before first round | – | unknown | D | 0% |
| 1 May 2017 | $4.58M | $1.67M – $12.6M | $6.28M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jun 2017 | $4.71M | $1.71M – $12.9M | $6.45M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jul 2017 | $4.83M | $1.76M – $13.3M | $6.62M (+37%) | before first round | – | unknown | D | 0% |
| 1 Aug 2017 | $4.96M | $1.81M – $13.6M | $6.80M (+37%) | before first round | – | unknown | D | 0% |
| 1 Sep 2017 | $5.10M | $1.85M – $14.0M | $6.99M (+37%) | before first round | – | unknown | D | 0% |
| 1 Oct 2017 | $5.23M | $1.90M – $14.4M | $7.17M (+37%) | before first round | – | unknown | D | 0% |
| 1 Nov 2017 | $5.37M | $1.96M – $14.8M | $7.36M (+37%) | before first round | – | unknown | D | 0% |
| 1 Dec 2017 | $5.51M | $2.01M – $15.1M | $7.56M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jan 2018 | $5.66M | $2.06M – $15.6M | $7.76M (+37%) | before first round | – | unknown | D | 0% |
| 1 Feb 2018 | $5.82M | $2.12M – $16.0M | $7.97M (+37%) | before first round | – | unknown | D | 0% |
| 1 Mar 2018 | $5.96M | $2.17M – $16.4M | $8.17M (+37%) | before first round | – | unknown | D | 0% |
| 1 Apr 2018 | $6.12M | $2.23M – $16.8M | $8.39M (+37%) | before first round | – | unknown | D | 0% |
| 1 May 2018 | $6.28M | $2.29M – $17.3M | $8.61M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jun 2018 | $6.45M | $2.35M – $17.7M | $8.85M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jul 2018 | $6.62M | $2.41M – $18.2M | $9.08M (+37%) | before first round | – | unknown | D | 0% |
| 1 Aug 2018 | $6.80M | $2.48M – $18.7M | $9.17M (+35%) | before first round | – | unknown | D | 0% |
| 1 Sep 2018 | $6.99M | $2.54M – $19.2M | $9.25M (+32%) | before first round | – | unknown | D | 0% |
| 1 Oct 2018 | $7.17M | $2.61M – $19.7M | $9.34M (+30%) | before first round | – | unknown | D | 0% |
| 1 Nov 2018 | $7.36M | $2.68M – $20.2M | $9.42M (+28%) | before first round | – | unknown | D | 0% |
| 1 Dec 2018 | $7.56M | $2.75M – $20.8M | $9.51M (+26%) | before first round | – | unknown | D | 0% |
| 1 Jan 2019 | $7.76M | $2.83M – $21.3M | $9.59M (+24%) | before first round | – | unknown | D | 0% |
| 1 Feb 2019 | $7.97M | $2.90M – $21.9M | $9.68M (+21%) | before first round | – | unknown | D | 0% |
| 1 Mar 2019 | $8.17M | $2.97M – $22.4M | $9.76M (+19%) | before first round | – | unknown | D | 0% |
| 1 Apr 2019 | $8.39M | $3.05M – $23.1M | $9.85M (+17%) | before first round | – | unknown | D | 0% |
| 1 May 2019 | $8.61M | $3.14M – $23.7M | $9.94M (+15%) | before first round | – | unknown | D | 0% |
| 1 Jun 2019 | $8.85M | $3.22M – $24.3M | $10.0M (+13%) | before first round | – | unknown | D | 0% |
| 1 Jul 2019 | $9.08M | $3.30M – $24.9M | $10.1M (+11%) | before first round | – | unknown | D | 0% |
| 1 Aug 2019 | $9.17M | $3.34M – $25.2M | $10.2M (+11%) | before first round | – | unknown | D | 0% |
| 1 Sep 2019 | $9.25M | $3.37M – $25.4M | $10.3M (+11%) | before first round | – | unknown | D | 0% |
| 1 Oct 2019 | $9.34M | $3.40M – $25.6M | $10.4M (+11%) | before first round | – | unknown | D | 0% |
| 1 Nov 2019 | $9.42M | $3.43M – $25.9M | $10.5M (+11%) | before first round | – | unknown | D | 0% |
| 1 Dec 2019 | $9.51M | $3.46M – $26.1M | $10.6M (+11%) | before first round | – | unknown | D | 0% |
| 1 Jan 2020 | $9.59M | $3.49M – $26.4M | $10.7M (+11%) | before first round | – | unknown | D | 0% |
| 1 Feb 2020 | $9.68M | $3.52M – $26.6M | $10.8M (+11%) | before first round | – | unknown | D | 0% |
| 1 Mar 2020 | $9.76M | $3.55M – $26.8M | $10.9M (+11%) | before first round | – | unknown | D | 0% |
| 1 Apr 2020 | $9.85M | $3.59M – $27.1M | $11.0M (+11%) | before first round | – | unknown | D | 0% |
| 1 May 2020 | $9.94M | $3.62M – $27.3M | $11.1M (+11%) | before first round | – | unknown | D | 0% |
| 1 Jun 2020 | $10.0M | $3.65M – $27.6M | $11.2M (+11%) | before first round | – | unknown | D | 0% |
| 1 Jul 2020 | $10.1M | $3.69M – $27.8M | $11.3M (+11%) | before first round | – | unknown | D | 0% |
| 1 Aug 2020 | $10.2M | $3.72M – $28.1M | $11.4M (+11%) | before first round | – | unknown | D | 0% |
| 1 Sep 2020 | $10.3M | $3.75M – $28.3M | $11.5M (+11%) | before first round | – | unknown | D | 0% |
| 11 Sep 2020 | $26.5M | $17.4M – $72.5M | $47.6M (+80%) | after a round | – | unknown | C | 0% |
| 1 Oct 2020 | $27.4M | $17.4M – $72.5M | $47.6M (+74%) | after a round | – | unknown | C | 0% |
| 1 Nov 2020 | $28.8M | $17.4M – $72.5M | $47.6M (+66%) | after a round | – | unknown | C | 0% |
| 1 Dec 2020 | $30.2M | $17.4M – $72.5M | $47.6M (+58%) | after a round | – | unknown | C | 0% |
| 1 Jan 2021 | $31.7M | $17.4M – $72.5M | $47.6M (+50%) | after a round | 22 | unknown | C | 0% |
| 1 Feb 2021 | $33.4M | $17.4M – $72.5M | $47.6M (+43%) | after a round | 22 | unknown | C | 0% |
| 1 Mar 2021 | $34.9M | $17.4M – $72.5M | $47.6M (+36%) | after a round | 22 | unknown | C | 0% |
| 1 Apr 2021 | $36.7M | $17.4M – $72.5M | $47.6M (+30%) | after a round | 22 | flat | C | 0% |
| 1 May 2021 | $38.5M | $17.4M – $72.5M | $47.6M (+24%) | after a round | 22 | flat | C | 0% |
| 1 Jun 2021 | $40.5M | $17.4M – $72.5M | $47.6M (+18%) | after a round | 22 | flat | C | 0% |
| 1 Jul 2021 | $42.5M | $17.4M – $72.5M | $47.6M (+12%) | after a round | 22 | flat | C | 0% |
| 1 Aug 2021 | $44.6M | $17.4M – $72.5M | $47.6M (+7%) | after a round | 22 | flat | C | 0% |
| 1 Sep 2021 | $46.9M | $17.4M – $72.5M | $47.6M (+1%) | after a round | 22 | flat | C | 0% |
| 1 Oct 2021 | $47.6M | $16.8M – $72.5M | $47.6M (0%) | after a round | 22 | flat | C | 0% |
| 1 Nov 2021 | $47.6M | $16.0M – $72.5M | $47.6M (0%) | after a round | 22 | flat | C | 0% |
| 1 Dec 2021 | $47.6M | $15.2M – $72.5M | $47.6M (0%) | after a round | 22 | flat | C | 0% |
| 1 Jan 2022 | $47.6M | $14.4M – $72.5M | $47.6M (0%) | after a round | 22 | flat | C | 0% |
| 1 Feb 2022 | $47.6M | $13.7M – $72.5M | $47.6M (0%) | after a round | 22 | flat | C | 0% |
| 1 Mar 2022 | $56.8M | $22.4M – $86.4M | $56.8M (0%) | after a round | 49 | growing | C | 0% |
| 1 Apr 2022 | $56.8M | $22.8M – $86.4M | $56.8M (0%) | after a round | 49 | growing | C | 0% |
| 1 May 2022 | $56.8M | $23.1M – $86.4M | $56.8M (0%) | after a round | 49 | growing | C | 0% |
| 1 Jun 2022 | $56.8M | $23.4M – $86.4M | $56.8M (0%) | after a round | 49 | growing | C | 0% |
| 1 Jul 2022 | $56.8M | $23.7M – $86.4M | $56.8M (0%) | after a round | 49 | growing | C | 0% |
| 1 Aug 2022 | $56.8M | $24.1M – $86.4M | $56.8M (0%) | after a round | 49 | growing | C | 0% |
| 1 Sep 2022 | $56.8M | $24.4M – $86.4M | $56.8M (0%) | after a round | 49 | growing | C | 0% |
| 1 Oct 2022 | $56.8M | $21.2M – $86.4M | $56.8M (0%) | after a round | 49 | growing | C | 0% |
| 1 Nov 2022 | $56.8M | $10.5M – $86.4M | $56.8M (0%) | after a round | 49 | unknown | D | 0% |
| 1 Dec 2022 | $56.8M | $9.95M – $86.4M | $56.8M (0%) | after a round | 49 | unknown | D | 0% |
| 1 Jan 2023 | $56.8M | $9.46M – $86.4M | $56.8M (0%) | after a round | 49 | unknown | D | 0% |
| 1 Feb 2023 | $56.8M | $8.99M – $86.4M | $56.8M (0%) | after a round | 49 | unknown | D | 0% |
| 1 Mar 2023 | $56.8M | $8.58M – $86.4M | $56.8M (0%) | after a round | 49 | unknown | D | 0% |
| 1 Apr 2023 | $56.8M | $8.16M – $86.4M | $56.8M (0%) | after a round | 49 | unknown | D | 0% |
| 1 May 2023 | $44.3M | $7.69M – $83.2M | $37.9M (-15%) | after a round | 47 | flat | D | 21% |
| 1 Jun 2023 | $44.1M | $7.31M – $83.7M | $37.3M (-15%) | after a round | 47 | flat | D | 21% |
| 1 Jul 2023 | $43.8M | $6.96M – $84.0M | $36.8M (-16%) | after a round | 47 | flat | D | 21% |
| 1 Aug 2023 | $43.6M | $6.61M – $84.5M | $36.2M (-17%) | after a round | 47 | flat | D | 21% |
| 1 Sep 2023 | $43.3M | $6.29M – $84.9M | $35.7M (-18%) | after a round | 47 | flat | D | 21% |
| 1 Oct 2023 | $44.7M | $7.89M – $83.8M | $39.8M (-11%) | after a round | 56 | up | D | 19% |
| 1 Nov 2023 | $45.2M | $7.58M – $83.9M | $40.5M (-10%) | after a round | 56 | up | D | 18% |
| 1 Dec 2023 | $45.7M | $7.30M – $83.9M | $41.2M (-10%) | after a round | 56 | up | D | 16% |
| 1 Jan 2024 | $46.2M | $7.01M – $83.8M | $41.9M (-9%) | after a round | 56 | up | D | 15% |
| 1 Feb 2024 | $46.6M | $6.74M – $83.8M | $42.4M (-9%) | after a round | 56 | up | D | 14% |
| 1 Mar 2024 | $50.4M | $15.9M – $89.8M | $47.8M (-5%) | after a round | 71 | growing | C | 13% |
| 1 Apr 2024 | $51.0M | $15.7M – $90.0M | $48.6M (-5%) | after a round | 71 | growing | C | 12% |
| 1 May 2024 | $51.6M | $15.6M – $90.2M | $49.3M (-4%) | after a round | 71 | growing | C | 11% |
| 1 Jun 2024 | $52.1M | $15.4M – $90.4M | $50.0M (-4%) | after a round | 71 | growing | C | 10% |
| 1 Jul 2024 | $52.6M | $15.2M – $90.6M | $50.7M (-4%) | after a round | 71 | growing | C | 9% |
| 1 Aug 2024 | $53.1M | $15.1M – $90.8M | $51.4M (-3%) | after a round | 71 | growing | C | 8% |
| 1 Sep 2024 | $53.6M | $14.9M – $91.0M | $52.2M (-3%) | after a round | 71 | growing | C | 8% |
| 1 Oct 2024 | $54.2M | $14.9M – $91.8M | $52.9M (-2%) | after a round | 71 | growing | C | 7% |
| 1 Nov 2024 | $54.6M | $14.7M – $91.9M | $53.5M (-2%) | after a round | 71 | growing | C | 6% |
| 1 Dec 2024 | $53.7M | $4.87M – $89.8M | $51.8M (-4%) | after a round | 71 | up | D | 6% |
| 1 Jan 2025 | $54.0M | $4.68M – $89.8M | $52.3M (-3%) | after a round | 71 | up | D | 5% |
| 1 Feb 2025 | $54.3M | $4.49M – $89.7M | $52.7M (-3%) | after a round | 71 | up | D | 5% |
| 1 Mar 2025 | $54.5M | $4.33M – $89.7M | $53.0M (-3%) | after a round | 71 | up | D | 5% |
| 1 Apr 2025 | $54.7M | $4.16M – $89.6M | $53.4M (-3%) | after a round | 71 | up | D | 4% |
| 17 Apr 2025 | $70.1M | $60.8M – $121M | $105M (+50%) | after a round | 71 | unknown | B | 0% |
| 1 May 2025 | $71.2M | $60.8M – $121M | $105M (+48%) | after a round | 71 | unknown | B | 0% |
| 1 Jun 2025 | $73.7M | $60.8M – $121M | $105M (+43%) | after a round | 71 | unknown | B | 0% |
| 1 Jul 2025 | $76.2M | $60.8M – $121M | $105M (+38%) | after a round | 88 | up | B | 0% |
| 1 Aug 2025 | $79.2M | $60.8M – $123M | $107M (+35%) | after a round | 94 | up | B | 0% |
| 1 Sep 2025 | $82.0M | $60.8M – $123M | $107M (+30%) | after a round | 94 | up | B | 0% |
| 1 Oct 2025 | $84.9M | $60.8M – $123M | $107M (+25%) | after a round | 94 | flat | B | 0% |
| 1 Nov 2025 | $89.3M | $60.8M – $126M | $109M (+23%) | after a round | 106 | up | B | 0% |
| 1 Dec 2025 | $92.6M | $60.8M – $126M | $109M (+18%) | after a round | 106 | up | B | 0% |
| 1 Jan 2026 | $96.2M | $60.8M – $126M | $109M (+14%) | after a round | 106 | up | B | 0% |
| 1 Feb 2026 | $99.9M | $60.8M – $126M | $109M (+9%) | after a round | 106 | up | B | 0% |
| 1 Mar 2026 | $103M | $60.8M – $126M | $109M (+6%) | after a round | 106 | up | B | 0% |
| 1 Apr 2026 | $110M | $60.8M – $129M | $112M (+2%) | after a round | 118 | up | B | 0% |
| 1 May 2026 | $113M | $61.4M – $130M | $113M (0%) | after a round | 122 | growing | B | 0% |
| 1 Jun 2026 | $113M | $62.5M – $130M | $113M (0%) | after a round | 122 | growing | B | 0% |
| 1 Jul 2026 | $113M | $63.6M – $130M | $113M (0%) | after a round | 122 | growing | B | 0% |
| 1 Aug 2026 | $113M | $64.8M – $130M | $113M (0%) | after a round | 124 | growing | B | 0% |
| 1 Sep 2026 | $114M | $66.1M – $131M | $114M (0%) | after a round | 126 | growing | B | 0% |
| 1 Oct 2026 | $113M | $67.3M – $130M | $113M (0%) | after a round | 125 | growing | B | 0% |
| 24 Oct 2026 | $113M | $68.2M – $130M | $113M (0%) | after a round | 125 | growing | B | 0% |
Key facts about Skin Analytics
- Founded
- 2012
- Headquarters
- London, United Kingdom
- Employees
- about 125 +18% in a year
- Total raised
- $25M
- Funding rounds
- 2
- Last round
- Series B Apr 2025
Skin Analytics funding history
Skin Analytics has 2 funding rounds on record, from Sep 2020 to Apr 2025, $25M in total. The latest disclosed valuation is $70M post-money (Series B, Apr 2025).
Series B 16 Apr 2025
Led by Intrepid Growth Partners.
Sources: skin-analytics.com, skin-analytics.com, crowdcube.com and 3 more
$20M
$70M post-money
Series A 10 Sep 2020
Led by Hoxton Ventures; with Nesta, MS+PARTNERS.
Sources: ukbaa.org.uk, techcrunch.com
$5.2M
Skin Analytics investors
4 investors have backed Skin Analytics; Hoxton Ventures and Intrepid Growth Partners led at least one round.
- Hoxton Ventures lead
- Nesta
What Skin Analytics does
Skin Analytics works in medical supply manufacturers, with 13 recorded offerings and customers in healthcare.
Skin Analytics is a British company that develops and deploys AI-driven dermatology solutions, including a Class III CE marked AI as a Medical Device (AIaMD) for teledermatology. The company provides remote skin assessment services and operates a custom-built teledermatology platform. Skin Analytics serves both patients and healthcare providers in the UK, Europe, and the US, and is ISO certified and CQC registered. The company also collaborates with healthcare organizations and research institutions to advance dermatology technology.
Description from Veridion's company data.
Products and services
- AI Dermatology Platform Development
- AI Skin Cancer Assessment Solutions
- Teledermatology Services
- Remote Skin Assessment Services
- Skin Cancer Pathway Implementation
- Dermatology Research and Innovation
- Healthcare Technology Deployment Services
- Patient Outcome Improvement Services
- Skin Condition Management Solutions
- Dermatology Resource Optimization Consulting
- AI Medical Device Manufacturing
- Clinical Advisory Services
- Healthcare Sustainability Consulting
Markets
- Healthcare
Technology
- AI-Driven Dermatology
- Teledermatology
Certifications
- ISO 27001
- ISO 13485
- CQC certified
Business model
- Business-to-Business
- Business-to-Consumer
- Service Provider
- Software-as-a-Service
Industry codes (NAICS)
- 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing 50% match
- 513210 Software Publishers 30% match
- 621999 All Other Miscellaneous Ambulatory Health Care Services 20% match
Questions about Skin Analytics
What is Skin Analytics worth?
Valuation $113M (range $68.2M to $130M), as of 24 Oct 2026. The last disclosed valuation was $70M (Series B, Apr 2025).
Has Skin Analytics raised money?
Skin Analytics has 2 funding rounds on record, from Sep 2020 to Apr 2025, $25M in total. The latest disclosed valuation is $70M post-money (Series B, Apr 2025).
Who has invested in Skin Analytics?
Hoxton Ventures, Intrepid Growth Partners, MS+PARTNERS and Nesta. Lead investors include Hoxton Ventures and Intrepid Growth Partners.
How many people work at Skin Analytics?
About 125, up 18% over the last year. Headcount grew from 22 in Jan 2021 to 125 in Sep 2026.
What does Skin Analytics do?
Skin Analytics works in medical supply manufacturers, with 13 recorded offerings and customers in healthcare. Its main offerings are AI dermatology platform development, AI skin cancer assessment solutions and teledermatology services.
When was Skin Analytics founded, and where is it based?
Skin Analytics was founded in 2012 and is based in London, United Kingdom. It has about 125 employees, up 18% over the last year.